Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cells

被引:14
|
作者
Cockbill, Louisa M. R. [1 ]
Murk, Kai [1 ]
Love, Seth [2 ]
Hanley, Jonathan G. [1 ]
机构
[1] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England
[2] Univ Bristol, Sch Clin Sci, Bristol BS10 5NB, Avon, England
基金
英国医学研究理事会;
关键词
ARP2/3-MEDIATED ACTIN POLYMERIZATION; ARP2/3; COMPLEX; EPH RECEPTORS; CONTACT INHIBITION; RHO GTPASES; PDZ DOMAIN; PICK1; GLIOMA; CANCER; MIGRATION;
D O I
10.1091/mbc.E15-05-0270
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Astrocytic tumors are the most common form of primary brain tumor. Astrocytic tumor cells infiltrate the surrounding CNS tissue, allowing them to evade removal upon surgical resection of the primary tumor. Dynamic changes to the actin cytoskeleton are crucial to cancer cell invasion, but the specific mechanisms that underlie the particularly invasive phenotype of astrocytic tumor cells are unclear. Protein interacting with C kinase 1 (PICK1) is a PDZ and BAR domain-containing protein that inhibits actin-related protein 2/3 (Arp2/3)-dependent actin polymerization and is involved in regulating the trafficking of a number of cellsurface receptors. Here we report that, in contrast to other cancers, PICK1 expression is down-regulated in grade IV astrocytic tumor cell lines and also in clinical cases of the disease in which grade IV tumors have progressed from lower-grade tumors. Exogenous expression of PICK1 in the grade IV astrocytic cell line U251 reduces their capacity for anchorage-independent growth, two-dimensional migration, and invasion through a three-dimensional matrix, strongly suggesting that low PICK1 expression plays an important role in astrocytic tumorigenesis. We propose that PICK1 negatively regulates neoplastic infiltration of astrocytic tumors and that manipulation of PICK1 is an attractive possibility for therapeutic intervention.
引用
收藏
页码:4552 / 4561
页数:10
相关论文
共 50 条
  • [21] ANCHORAGE-INDEPENDENT GROWTH-CONFERRING FACTOR PRODUCTION BY RAT MAMMARY-TUMOR CELLS
    ZWIEBEL, JA
    DAVIS, MR
    KOHN, E
    SALOMON, DS
    KIDWELL, WR
    CANCER RESEARCH, 1982, 42 (12) : 5117 - 5125
  • [22] Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells
    Chen, Sen
    Bu, Guojun
    Takei, Yoshifumi
    Sakamoto, Kazuma
    Ikematsu, Shinya
    Muramatsu, Takashi
    Kadomatsu, Kenji
    JOURNAL OF CELL SCIENCE, 2007, 120 (22) : 4009 - 4015
  • [24] Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells
    Wise, Randi
    Duhachek-Muggy, Sara
    Qi, Yue
    Zolkiewski, Michal
    Zolkiewska, Anna
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 241 - 252
  • [25] Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth
    Hervieu, Alexia
    Kermorgant, Stephanie
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [26] Caveolin-1 expression abrogates anchorage-independent growth in oncogenically transformed cells
    Engelman, J
    Wykoff, C
    Yasuhara, S
    Song, K
    Okamoto, T
    Lisanti, MP
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 2051 - 2051
  • [27] Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells
    Wise, Randi
    Duhachek-Muggy, Sara
    Qi, Yue
    Zolkiewski, Michel
    Zolkiewska, Anna
    CANCER RESEARCH, 2016, 76
  • [28] Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent Growth
    DeRita, Rachel M.
    Sayeed, Aejaz
    Garcia, Vaughn
    Krishn, Shiv Ram
    Shields, Christopher D.
    Sarker, Srawasti
    Friedman, Andrea
    McCue, Peter
    Molugu, Sudheer Kumar
    Rodeck, Ulrich
    Dicker, Adam P.
    Languino, Lucia R.
    ISCIENCE, 2019, 14 : 199 - +
  • [29] PTCH1 regulates anchorage-independent growth and bone invasion of non-small cell lung cancer cells
    Choi, Ji-Yoon
    Lee, Yun Sun
    Shim, Da Mi
    Seo, Sung Wook
    BONE, 2021, 144
  • [30] Fusicoccin derivative (ISIR-005) suppresses anchorage-independent growth of cancer cells through anoikis activation
    Honma, Y.
    Akimoto, M.
    Sassa, T.
    Kato, N.
    EJC SUPPLEMENTS, 2008, 6 (12): : 59 - 59